« back

Versus Arthritis

  Monday, 07 Nov 2022 | Funding Deadline

The following funding opportunities are open for application:

Priorities 2023: Accelerating diagnosis and treatment (closing date: 9 November 2022)
Versus Arthritis want to bring about more accurate and faster diagnosis and more timely, effective and targeted treatments, tailored to individuals, taking into consideration not just their genes but also the environment they live in. The Better Lives Today, Better Lives Tomorrow Research Strategy 2022-2026 focusses their investment and influence on four priority areas over the next four years. It is striving to bring ground-breaking scientific discoveries to people with arthritis at pace and with precision.

This call for applications for research funding focusses on two of the priority areas:

• Early detection and prevention: spotting the biological signatures of arthritis early to maximise the opportunities for timely intervention and preventing it from getting worse.
• Targeted treatments: taking the guesswork out of treatment by increasing effective, reliable and timely drug and non-drug solutions to reduce, manage or cure disease.

Fatigue evidence review 2023 (closing date: 7 November 2022)
Versus Arthritis are looking to fund a single proposal that can generate a substantial and well-evidenced scoping review that comprehensively covers how chronic fatigue is measured, assessed, and treated. Reviews should include scientific and clinical evidence, as well as meaningful inclusion of the needs of people living with chronic fatigue. They expect the primary focus of the review to be on musculoskeletal fatigue, but encourage cross-disease applications, including outside musculoskeletal diseases where chronic fatigue is a key component.